Winship Cancer Institute Cancer Center Support Grant View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2009-2022

FUNDING AMOUNT

19018956 USD

ABSTRACT

PROJECT SUMMARY/ABSTRACT The Winship Cancer Institute of Emory University (Winship) is the only NCI-designated cancer center in Georgia, which is now the eighth most populous state and has the largest land area among states east of the Mississippi River. As the main tertiary cancer care and cancer research institution in the state, Winship has committed its four research programs as supported by its six shared resources to address the specific challenges associated with the cancer burden in Georgia. These challenges include: high tobacco usage and incidence of tobacco- related cancers; high proportion of cancer patients who are African American or black and/or have significant cancer disparity issues in their care, prognosis, and/or outcome; and low health literacy levels. Winship's mission is to lessen the burden of cancer for the citizens of Georgia, its primary catchment area. This will be accomplished by: (1) seeking greater insights into the molecular, genetic, and epigenetic basis of cancer; (2) discovering new knowledge that drives improvements in cancer detection, prevention, and/or therapy; (3) developing or defining novel therapeutic targets and/or agents as a pathway to better cancer therapies; and (4) studying and implementing population-based strategies to lessen the cancer burden in the state. The 164 Winship core members are actively engaged in one of four Winship research programs, all of which have a strong emphasis on transdisciplinary research: Cancer Cell Biology, Cancer Genetics and Epigenetics, Cancer Prevention and Control, and Discovery and Developmental Therapeutics. Winship's members are supported by six shared resources: Biostatistics and Bioinformatics Shared Resource, Cancer Animal Models Shared Resource, Cancer Tissue and Pathology Shared Resource, Emory Integrated Genomics Shared Resource, Emory Integrated Proteomics Shared Resource, and the Integrated Imaging Shared Resource; and two developing shared resources: Winship Research Informatics and Intervention Development, Dissemination, and Implementation Developing Shared Resources. Winship members are currently supported by $84.8M in total research funding (as of 3/31/2016) awarded via Emory University. Winship members Curran and Bruner serve as PIs on two NCI awards to the NRG Oncology Foundation for a total of $25.6M in support of clinical research infrastructure. Patient enrollment in Winship's interventional and non-interventional trials continues to increase, especially among patients from under-represented minority groups, and these activities have contributed to the FDA- approval of several novel anti-cancer agents during the present funding period. Winship has outstanding institutional commitment, with more than $200 million in institutional support committed over the next five years, a level almost twice that committed in 2011. Winship enjoys the same reporting line and organizational position as Emory's schools of medicine, public health, and nursing. Winship is uniquely positioned to apply its scientific strengths, outstanding membership, robust infrastructure, strong institutional support, and comprehensive training programs to fulfill its mission of lessening the burden of cancer on the state of Georgia and beyond. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9480731

Related SciGraph Publications

  • 2019-12. A simple genotyping method to detect small CRISPR-Cas9 induced indels by agarose gel electrophoresis in SCIENTIFIC REPORTS
  • 2019-12. The prodomain of caspase-3 regulates its own removal and caspase activation in CELL DEATH DISCOVERY
  • 2019-12. Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function in SCIENTIFIC REPORTS
  • 2019-04. HPV Vaccine-Related Research, Promotion and Coordination in the State of Georgia: A Systematic Review in JOURNAL OF COMMUNITY HEALTH
  • 2019-03. Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes in CLINICAL AND TRANSLATIONAL ONCOLOGY
  • 2019-02-06. Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials in INVESTIGATIONAL NEW DRUGS
  • 2019-02-06. Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death in JOURNAL OF NEURO-ONCOLOGY
  • 2019-01-24. Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma in LEUKEMIA
  • 2018-12-12. Human Papillomavirus Vaccination in Georgia: Evaluating the Georgia HPV Work Group in JOURNAL OF COMMUNITY HEALTH
  • 2018-12. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways in NPJ PRECISION ONCOLOGY
  • 2018-12. B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation in NATURE COMMUNICATIONS
  • 2018-12. Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer in SCIENTIFIC REPORTS
  • 2018-12. Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts in SCIENTIFIC REPORTS
  • 2018-12. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia in TRANSLATIONAL PSYCHIATRY
  • 2018-12. TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics in SCIENTIFIC REPORTS
  • 2018-09-06. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma in HEAD AND NECK PATHOLOGY
  • 2018-09. Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-09. TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer in ONCOGENESIS
  • 2018-09. Selective modification of fluciclovine (18F) transport in prostate carcinoma xenografts in AMINO ACIDS
  • 2018-09. Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery in JOURNAL OF NEURO-ONCOLOGY
  • 2018-06-12. What does plasma CRP tell us about peripheral and central inflammation in depression? in MOLECULAR PSYCHIATRY
  • 2018-06. Musculoskeletal outcomes and the effect of radiation to the vertebral bodies on growth trajectories for long-term survivors of high-risk neuroblastoma in JOURNAL OF RADIATION ONCOLOGY
  • 2018-04. Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2018-04. Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2018-03. Downstream Breast Imaging Following Screening Mammography in Medicare Patients with Advanced Cancer: A Population-Based Study in JOURNAL OF GENERAL INTERNAL MEDICINE
  • 2018-01. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery in JOURNAL OF NEURO-ONCOLOGY
  • 2017-12. 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins in SCIENTIFIC REPORTS
  • 2017-12. DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion in CELL COMMUNICATION AND SIGNALING
  • 2017-12. Coordinated cell motility is regulated by a combination of LKB1 farnesylation and kinase activity in SCIENTIFIC REPORTS
  • 2017-12. Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics in SCIENTIFIC REPORTS
  • 2017-10-19. OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc in ONCOGENE
  • 2017-08-10. Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression in ONCOGENE
  • 2017-05-12. Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion in NATURE COMMUNICATIONS
  • 2017-02-16. The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies in NATURE COMMUNICATIONS
  • 2017-01. Inflammation Effects on Motivation and Motor Activity: Role of Dopamine in NEUROPSYCHOPHARMACOLOGY
  • 2016-12. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy in RADIATION ONCOLOGY
  • 2016-12. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016-12. GIFT4 fusokine converts leukemic B cells into immune helper cells in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016-12. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups in ACTA NEUROPATHOLOGICA COMMUNICATIONS
  • 2016-11. Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase in ONCOGENE
  • 2016-10. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression in MOLECULAR PSYCHIATRY
  • 2016-09. Young Adult Cancer Survivors’ Experience with Cancer Treatment and Follow-Up Care and Perceptions of Barriers to Engaging in Recommended Care in JOURNAL OF CANCER EDUCATION
  • 2016-08. Distinct health behavior and psychosocial profiles of young adult survivors of childhood cancers: a mixed methods study in JOURNAL OF CANCER SURVIVORSHIP
  • 2016-08. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells in ONCOGENE
  • 2016-07-25. Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactions in NATURE COMMUNICATIONS
  • 2016-07. Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax in ONCOGENE
  • 2016-06-08. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis in NATURE COMMUNICATIONS
  • 2016-06. CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation in DERMATOLOGY AND THERAPY
  • 2016-02. Nanoscale optomechanical actuators for controlling mechanotransduction in living cells in NATURE METHODS
  • 2016-01. Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia in ONCOGENE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "19018956"
        }, 
        "description": "PROJECT SUMMARY/ABSTRACT The Winship Cancer Institute of Emory University (Winship) is the only NCI-designated cancer center in Georgia, which is now the eighth most populous state and has the largest land area among states east of the Mississippi River. As the main tertiary cancer care and cancer research institution in the state, Winship has committed its four research programs as supported by its six shared resources to address the specific challenges associated with the cancer burden in Georgia. These challenges include: high tobacco usage and incidence of tobacco- related cancers; high proportion of cancer patients who are African American or black and/or have significant cancer disparity issues in their care, prognosis, and/or outcome; and low health literacy levels. Winship's mission is to lessen the burden of cancer for the citizens of Georgia, its primary catchment area. This will be accomplished by: (1) seeking greater insights into the molecular, genetic, and epigenetic basis of cancer; (2) discovering new knowledge that drives improvements in cancer detection, prevention, and/or therapy; (3) developing or defining novel therapeutic targets and/or agents as a pathway to better cancer therapies; and (4) studying and implementing population-based strategies to lessen the cancer burden in the state. The 164 Winship core members are actively engaged in one of four Winship research programs, all of which have a strong emphasis on transdisciplinary research: Cancer Cell Biology, Cancer Genetics and Epigenetics, Cancer Prevention and Control, and Discovery and Developmental Therapeutics. Winship's members are supported by six shared resources: Biostatistics and Bioinformatics Shared Resource, Cancer Animal Models Shared Resource, Cancer Tissue and Pathology Shared Resource, Emory Integrated Genomics Shared Resource, Emory Integrated Proteomics Shared Resource, and the Integrated Imaging Shared Resource; and two developing shared resources: Winship Research Informatics and Intervention Development, Dissemination, and Implementation Developing Shared Resources. Winship members are currently supported by $84.8M in total research funding (as of 3/31/2016) awarded via Emory University. Winship members Curran and Bruner serve as PIs on two NCI awards to the NRG Oncology Foundation for a total of $25.6M in support of clinical research infrastructure. Patient enrollment in Winship's interventional and non-interventional trials continues to increase, especially among patients from under-represented minority groups, and these activities have contributed to the FDA- approval of several novel anti-cancer agents during the present funding period. Winship has outstanding institutional commitment, with more than $200 million in institutional support committed over the next five years, a level almost twice that committed in 2011. Winship enjoys the same reporting line and organizational position as Emory's schools of medicine, public health, and nursing. Winship is uniquely positioned to apply its scientific strengths, outstanding membership, robust infrastructure, strong institutional support, and comprehensive training programs to fulfill its mission of lessening the burden of cancer on the state of Georgia and beyond.", 
        "endDate": "2022-03-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438879", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438879"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA138292"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "epigenetic basis", 
          "Emory Integrated Proteomics Shared Resource", 
          "total research funding", 
          "new knowledge", 
          "Pathology Shared Resource", 
          "Winship core members", 
          "Winship members Curran", 
          "cancer", 
          "significant cancer disparity issues", 
          "low health literacy levels", 
          "organizational position", 
          "patient enrollment", 
          "only NCI", 
          "cancer prevention", 
          "Developmental Therapeutics", 
          "primary catchment area", 
          "dissemination", 
          "levels", 
          "clinical research infrastructure", 
          "specific challenges", 
          "patients", 
          "scientific strength", 
          "prognosis", 
          "outcome", 
          "cancer detection", 
          "PROJECT SUMMARY/ABSTRACT", 
          "novel therapeutic targets", 
          "population", 
          "better cancer therapies", 
          "comprehensive training program", 
          "Integrated Imaging Shared Resource", 
          "Winship Research Informatics", 
          "NCI awards", 
          "intervention development", 
          "strong emphasis", 
          "citizens", 
          "support", 
          "Bruner", 
          "prevention", 
          "high tobacco usage", 
          "FDA- approval", 
          "incidence", 
          "research program", 
          "pathway", 
          "biostatistics", 
          "Winship's mission", 
          "cancer center", 
          "cancer patients", 
          "care", 
          "Emory School", 
          "same reporting line", 
          "agents", 
          "public health", 
          "shared resources", 
          "high proportion", 
          "Pi", 
          "Cancer Animal Models Shared Resource", 
          "Winship Cancer Institute Cancer Center Support Grant", 
          "tobacco-", 
          "cancer burden", 
          "main tertiary cancer care", 
          "cancer research institutions", 
          "nursing", 
          "years", 
          "Winship research programs", 
          "Georgia", 
          "outstanding membership", 
          "Epigenetics", 
          "present funding period", 
          "strategies", 
          "Emory University", 
          "Cancer Genetics", 
          "Winship members", 
          "Implementation Developing Shared Resources", 
          "therapy", 
          "populous state", 
          "improvement", 
          "large land areas", 
          "challenges", 
          "minority groups", 
          "outstanding institutional commitment", 
          "institutional support", 
          "resources", 
          "transdisciplinary research", 
          "Bioinformatics Shared Resource", 
          "discovery", 
          "activity", 
          "NRG Oncology Foundation", 
          "cancer tissues", 
          "robust infrastructure", 
          "mission", 
          "burden", 
          "control", 
          "medicine", 
          "Winship", 
          "several novel anti-cancer agents", 
          "strong institutional support", 
          "cancer cell biology", 
          "total", 
          "Winship Cancer Institute", 
          "Mississippi River", 
          "state", 
          "non-interventional trial", 
          "Emory Integrated Genomics Shared Resource", 
          "greater insight"
        ], 
        "name": "Winship Cancer Institute Cancer Center Support Grant", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.189967.8", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.189967.8", 
              "name": "EMORY UNIVERSITY", 
              "type": "Organization"
            }, 
            "familyName": "CURRAN", 
            "givenName": "WALTER J.", 
            "id": "sg:person.01016457503.10", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.01016457503.10", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438879"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "2009-04-07T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9480731"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438879'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438879'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438879'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438879'


     

    This table displays all metadata directly associated to this object as RDF triples.

    149 TRIPLES      19 PREDICATES      126 URIs      118 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438879 schema:about anzsrc-for:2211
    2 schema:amount N01ca49399f4147e2b9128b34a334c4fd
    3 schema:description PROJECT SUMMARY/ABSTRACT The Winship Cancer Institute of Emory University (Winship) is the only NCI-designated cancer center in Georgia, which is now the eighth most populous state and has the largest land area among states east of the Mississippi River. As the main tertiary cancer care and cancer research institution in the state, Winship has committed its four research programs as supported by its six shared resources to address the specific challenges associated with the cancer burden in Georgia. These challenges include: high tobacco usage and incidence of tobacco- related cancers; high proportion of cancer patients who are African American or black and/or have significant cancer disparity issues in their care, prognosis, and/or outcome; and low health literacy levels. Winship's mission is to lessen the burden of cancer for the citizens of Georgia, its primary catchment area. This will be accomplished by: (1) seeking greater insights into the molecular, genetic, and epigenetic basis of cancer; (2) discovering new knowledge that drives improvements in cancer detection, prevention, and/or therapy; (3) developing or defining novel therapeutic targets and/or agents as a pathway to better cancer therapies; and (4) studying and implementing population-based strategies to lessen the cancer burden in the state. The 164 Winship core members are actively engaged in one of four Winship research programs, all of which have a strong emphasis on transdisciplinary research: Cancer Cell Biology, Cancer Genetics and Epigenetics, Cancer Prevention and Control, and Discovery and Developmental Therapeutics. Winship's members are supported by six shared resources: Biostatistics and Bioinformatics Shared Resource, Cancer Animal Models Shared Resource, Cancer Tissue and Pathology Shared Resource, Emory Integrated Genomics Shared Resource, Emory Integrated Proteomics Shared Resource, and the Integrated Imaging Shared Resource; and two developing shared resources: Winship Research Informatics and Intervention Development, Dissemination, and Implementation Developing Shared Resources. Winship members are currently supported by $84.8M in total research funding (as of 3/31/2016) awarded via Emory University. Winship members Curran and Bruner serve as PIs on two NCI awards to the NRG Oncology Foundation for a total of $25.6M in support of clinical research infrastructure. Patient enrollment in Winship's interventional and non-interventional trials continues to increase, especially among patients from under-represented minority groups, and these activities have contributed to the FDA- approval of several novel anti-cancer agents during the present funding period. Winship has outstanding institutional commitment, with more than $200 million in institutional support committed over the next five years, a level almost twice that committed in 2011. Winship enjoys the same reporting line and organizational position as Emory's schools of medicine, public health, and nursing. Winship is uniquely positioned to apply its scientific strengths, outstanding membership, robust infrastructure, strong institutional support, and comprehensive training programs to fulfill its mission of lessening the burden of cancer on the state of Georgia and beyond.
    4 schema:endDate 2022-03-31T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N2a7f388676b243bfb611b673bf484082
    7 N2dd9bcd776174a26904fa71f3f47324d
    8 schema:inLanguage en
    9 schema:keywords Bioinformatics Shared Resource
    10 Bruner
    11 Cancer Animal Models Shared Resource
    12 Cancer Genetics
    13 Developmental Therapeutics
    14 Emory Integrated Genomics Shared Resource
    15 Emory Integrated Proteomics Shared Resource
    16 Emory School
    17 Emory University
    18 Epigenetics
    19 FDA- approval
    20 Georgia
    21 Implementation Developing Shared Resources
    22 Integrated Imaging Shared Resource
    23 Mississippi River
    24 NCI awards
    25 NRG Oncology Foundation
    26 PROJECT SUMMARY/ABSTRACT
    27 Pathology Shared Resource
    28 Pi
    29 Winship
    30 Winship Cancer Institute
    31 Winship Cancer Institute Cancer Center Support Grant
    32 Winship Research Informatics
    33 Winship core members
    34 Winship members
    35 Winship members Curran
    36 Winship research programs
    37 Winship's mission
    38 activity
    39 agents
    40 better cancer therapies
    41 biostatistics
    42 burden
    43 cancer
    44 cancer burden
    45 cancer cell biology
    46 cancer center
    47 cancer detection
    48 cancer patients
    49 cancer prevention
    50 cancer research institutions
    51 cancer tissues
    52 care
    53 challenges
    54 citizens
    55 clinical research infrastructure
    56 comprehensive training program
    57 control
    58 discovery
    59 dissemination
    60 epigenetic basis
    61 greater insight
    62 high proportion
    63 high tobacco usage
    64 improvement
    65 incidence
    66 institutional support
    67 intervention development
    68 large land areas
    69 levels
    70 low health literacy levels
    71 main tertiary cancer care
    72 medicine
    73 minority groups
    74 mission
    75 new knowledge
    76 non-interventional trial
    77 novel therapeutic targets
    78 nursing
    79 only NCI
    80 organizational position
    81 outcome
    82 outstanding institutional commitment
    83 outstanding membership
    84 pathway
    85 patient enrollment
    86 patients
    87 population
    88 populous state
    89 present funding period
    90 prevention
    91 primary catchment area
    92 prognosis
    93 public health
    94 research program
    95 resources
    96 robust infrastructure
    97 same reporting line
    98 scientific strength
    99 several novel anti-cancer agents
    100 shared resources
    101 significant cancer disparity issues
    102 specific challenges
    103 state
    104 strategies
    105 strong emphasis
    106 strong institutional support
    107 support
    108 therapy
    109 tobacco-
    110 total
    111 total research funding
    112 transdisciplinary research
    113 years
    114 schema:name Winship Cancer Institute Cancer Center Support Grant
    115 schema:recipient N1d459cab0b19442e856c987f2ce0c429
    116 sg:person.01016457503.10
    117 https://www.grid.ac/institutes/grid.189967.8
    118 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438879
    119 schema:sdDatePublished 2019-03-07T12:11
    120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    121 schema:sdPublisher N0b42e95fa496497bb03f2a25cbf53dd0
    122 schema:startDate 2009-04-07T00:00:00Z
    123 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9480731
    124 sgo:license sg:explorer/license/
    125 sgo:sdDataset grants
    126 rdf:type schema:MonetaryGrant
    127 N01ca49399f4147e2b9128b34a334c4fd schema:currency USD
    128 schema:value 19018956
    129 rdf:type schema:MonetaryAmount
    130 N0b42e95fa496497bb03f2a25cbf53dd0 schema:name Springer Nature - SN SciGraph project
    131 rdf:type schema:Organization
    132 N1d459cab0b19442e856c987f2ce0c429 schema:member sg:person.01016457503.10
    133 schema:roleName PI
    134 rdf:type schema:Role
    135 N2a7f388676b243bfb611b673bf484082 schema:name nih_id
    136 schema:value P30CA138292
    137 rdf:type schema:PropertyValue
    138 N2dd9bcd776174a26904fa71f3f47324d schema:name dimensions_id
    139 schema:value 2438879
    140 rdf:type schema:PropertyValue
    141 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    142 rdf:type schema:DefinedTerm
    143 sg:person.01016457503.10 schema:affiliation https://www.grid.ac/institutes/grid.189967.8
    144 schema:familyName CURRAN
    145 schema:givenName WALTER J.
    146 rdf:type schema:Person
    147 https://www.grid.ac/institutes/grid.189967.8 schema:name EMORY UNIVERSITY
    148 rdf:type schema:Organization
    149 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...